Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Abstract

Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.

Vibeke Strand, David L Scott, Paul Emery, Joachim R Kalden, Josef S Smolen, Grant W Cannon, Peter Tugwell, Bruce Crawford and Leflunomide Rheumatoid Arthritis Investigators Groups
The Journal of Rheumatology April 2005, 32 (4) 590-601;
Vibeke Strand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David L Scott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Emery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joachim R Kalden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josef S Smolen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grant W Cannon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Tugwell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Crawford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 32 no. 4 590-601
PubMed 
15801012

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online April 1, 2005.


Author Information

  1. Vibeke Strand,
  2. David L Scott,
  3. Paul Emery,
  4. Joachim R Kalden,
  5. Josef S Smolen,
  6. Grant W Cannon,
  7. Peter Tugwell,
  8. Bruce Crawford, and
  9. Leflunomide Rheumatoid Arthritis Investigators Groups
  1. Division of Immunology, Stanford University School of Medicine, Palo Alto, California, USA.

Article usage

Article usage: January 2009 to October 2023

AbstractFullPdf
Jan 20092901
Feb 20092604
Mar 20092502
Apr 20093505
May 20091807
Jun 200919011
Jul 20092003
Aug 200922010
Sep 200922011
Oct 200920017
Nov 200932021
Dec 200932011
Jan 20102506
Feb 20103000
Mar 201042010
Apr 20101906
May 20102004
Jun 20101609
Jul 20101903
Aug 201021010
Sep 20103109
Oct 201019012
Nov 20101402
Dec 20103002
Jan 201116010
Feb 20111805
Mar 20112708
Apr 20111604
May 20111901
Jun 20112606
Jul 201124110
Aug 20112602
Sep 20112607
Oct 20111000
Nov 20112305
Dec 20111305
Jan 20122504
Feb 20123902
Mar 201235010
Apr 20122008
May 20122905
Jun 20121305
Jul 20121504
Aug 20121126
Sep 20122402
Oct 20122503
Nov 20121903
Dec 20121801
Jan 20138304
Feb 20131407
Mar 201322010
Apr 20132401
May 20132604
Jun 20131203
Jul 2013902
Aug 20131107
Sep 2013807
Oct 20132102
Nov 20131003
Dec 2013602
Jan 20141205
Feb 20141200
Mar 2014801
Apr 2014902
May 20141804
Jun 20141108
Jul 2014401
Aug 2014402
Sep 20141206
Oct 20141604
Nov 20141501
Dec 20141804
Jan 20151100
Feb 2015602
Mar 20151705
Apr 20151106
May 20151102
Jun 20151803
Jul 20151402
Aug 20151304
Sep 20151003
Oct 20151103
Nov 2015706
Dec 2015602
Jan 20162900
Feb 2016701
Mar 201617012
Apr 20161001
May 20162018
Jun 20161303
Jul 20161000
Aug 20161208
Sep 2016302
Oct 2016901
Nov 2016901
Dec 20163202
Jan 20172704
Feb 20171901
Mar 20173003
Apr 20171502
May 20172203
Jun 20173002
Jul 20173403
Aug 20171001
Sep 2017703
Oct 20172102
Nov 20174003
Dec 20172001
Jan 2018701
Feb 20183202
Mar 20182501
Apr 20181602
May 20182902
Jun 20182100
Jul 20181000
Aug 20183002
Sep 20181905
Oct 20182904
Nov 20182903
Dec 20182202
Jan 20192105
Feb 20192202
Mar 20192501
Apr 20192905
May 20192701
Jun 20192704
Jul 20191803
Aug 2019200
Sep 20192802
Oct 20191400
Nov 20191601
Dec 20191801
Jan 2020905
Feb 2020701
Mar 20201308
Apr 202021016
May 20208013
Jun 20206010
Jul 2020707
Aug 20201006
Sep 2020903
Oct 20201004
Nov 2020904
Dec 2020903
Jan 20211209
Feb 202124018
Mar 20211207
Apr 20211407
May 20216003
Jun 20211205
Jul 2021607
Aug 20211104
Sep 20211706
Oct 202112010
Nov 202131012
Dec 2021805
Jan 2022902
Feb 2022402
Mar 20222804
Apr 202234014
May 202214011
Jun 2022705
Jul 2022606
Aug 20221106
Sep 2022503
Oct 2022702
Nov 20221005
Dec 2022201
Jan 202315011
Feb 20231107
Mar 2023505
Apr 2023902
May 202315010
Jun 20231003
Jul 2023706
Aug 2023507
Sep 202320010
Oct 20232103

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 32, Issue 4
1 Apr 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
Vibeke Strand, David L Scott, Paul Emery, Joachim R Kalden, Josef S Smolen, Grant W Cannon, Peter Tugwell, Bruce Crawford, Leflunomide Rheumatoid Arthritis Investigators Groups
The Journal of Rheumatology Apr 2005, 32 (4) 590-601;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
Vibeke Strand, David L Scott, Paul Emery, Joachim R Kalden, Josef S Smolen, Grant W Cannon, Peter Tugwell, Bruce Crawford, Leflunomide Rheumatoid Arthritis Investigators Groups
The Journal of Rheumatology Apr 2005, 32 (4) 590-601;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2023 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire